Narwhal Capital Management Amgen Inc Transaction History

Narwhal Capital Management

$1.09 Billion
Q3 2024

A detailed history of Narwhal Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Narwhal Capital Management holds 5,127 shares of AMGN stock, worth $1.62 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,127

Previous 5,147 0.39%

Holding current value

$1.62 Million

Previous $1.61 Million 2.67%

% of portfolio

0.15%

Previous 0.15%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $6,187 - $6,747	-20 Reduced 0.39%	5,127 $1.65 Million
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $12,349 - $15,007	-47 Reduced 0.9%	5,147 $1.61 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $65,714 - $74,134	-257 Reduced 4.71%	5,194 $1.5 Million
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $72,810 - $90,396	-333 Reduced 5.76%	5,451 $1.47 Million
Q2 2023 Aug 02, 2023	SELL	$214.27 - $253.37 $19,712 - $23,310	-92 Reduced 1.57%	5,784 $1.28 Million
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $2,935 - $3,577	-13 Reduced 0.22%	5,876 $1.42 Million
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $14,428 - $18,333	63 Added 1.08%	5,889 $1.55 Million
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $42,647 - $48,098	190 Added 3.37%	5,826 $1.31 Million
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $193,565 - $215,404	839 Added 17.49%	5,636 $1.37 Million
Q1 2022 Apr 26, 2022	SELL	$219.27 - $242.57 $187,695 - $207,639	-856 Reduced 15.14%	4,797 $1.16 Million
Q4 2021 Jan 26, 2022	SELL	$198.88 - $227.6 $52,703 - $60,314	-265 Reduced 4.48%	5,653 $1.27 Million
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $421,143 - $493,420	-1,984 Reduced 25.11%	5,918 $1.26 Million
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $359,946 - $399,334	-1,541 Reduced 16.32%	7,902 $1.93 Million
Q1 2021 Apr 23, 2021	SELL	$221.91 - $258.6 $240,772 - $280,581	-1,085 Reduced 10.31%	9,443 $2.35 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $341,880 - $407,118	1,580 Added 17.66%	10,528 $2.42 Million
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $201,799 - $224,417	860 Added 10.63%	8,948 $2.27 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $3,164 - $3,883	16 Added 0.2%	8,088 $1.91 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $378,694 - $502,252	2,078 Added 34.67%	8,072 $1.64 Million
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $10,595 - $13,619	56 Added 0.94%	5,994 $1.45 Million
Q3 2019 Oct 31, 2019	BUY	$174.11 - $208.62 $217,463 - $260,566	1,249 Added 26.64%	5,938 $1.15 Million
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $116,356 - $136,396	698 Added 17.49%	4,689 $864,000
Q3 2018 Oct 23, 2018	BUY	$185.29 - $208.89 $7,596 - $8,564	41 Added 1.04%	3,991 $827,000
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $640,953 - $719,928	-3,860 Reduced 49.42%	3,950 $729,000
Q1 2018 Apr 17, 2018	SELL	$169.43 - $198.0 $1.86 Million - $2.17 Million	-10,950 Reduced 58.37%	7,810 $1.33 Million
Q4 2017 Jan 23, 2018	BUY	$168.79 - $188.59 $42,197 - $47,147	250 Added 1.35%	18,760 $3.26 Million
Q3 2017 Oct 17, 2017	BUY	$167.29 - $191.0 $3.1 Million - $3.54 Million	18,510	18,510 $3.45 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.29M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Narwhal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Narwhal Capital Management with notifications on news.

Account

Narwhal Capital Management Amgen Inc Transaction History